by Kevin Doe | Aug 23, 2021 | Free Press Releases
Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as...
by Kevin Doe | Aug 16, 2021 | Free Press Releases
Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access Roots Analysis is pleased...
by Kevin Doe | Aug 16, 2021 | Free Press Releases
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs Roots Analysis is pleased...
by Kevin Doe | Aug 2, 2021 | Free Press Releases
The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research Report Keywords- RNAi Therapeutics, Therapeutics, Research, RootsAnalysis, Biotech Roots...
